User profiles for A. Fox-Robichaud

Alison Fox-Robichaud

Professor, Department of Medicine, McMaster University
Verified email at mcmaster.ca
Cited by 6250

Fluid resuscitation in sepsis: a systematic review and network meta-analysis

…, L Thabane, A Fox-Robichaud… - Annals of internal …, 2014 - acpjournals.org
Background: Fluid resuscitation is the cornerstone of sepsis treatment. However, whether
balanced or unbalanced crystalloids or natural or synthetic colloids confer a survival …

[HTML][HTML] Restricted visitation policies in acute care settings during the COVID-19 pandemic: a scoping review

…, KEA Burns, DJ Cook, CJ Doig, A Fox-Robichaud… - Critical Care, 2021 - Springer
Background Restricted visitation policies in acute care settings because of the COVID-19
pandemic have negative consequences. The objective of this scoping review is to identify …

[PDF][PDF] Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis

…, PM Kowalewska, W Alhazzan, AE Fox-Robichaud - Can J Urol, 2013 - researchgate.net
Materials and methods: MEDLINE and EMBASE were searched from inception to July 2012
for RCTs using a Lactobacillus prophylactic against rUTI in premenopausal adult women. A …

[HTML][HTML] Prognostic utility and characterization of cell-free DNA in patients with severe sepsis

…, KL Liaw, JI Weitz, DJ Cook, AE Fox-Robichaud… - Critical care, 2012 - Springer
Introduction Although sepsis is the leading cause of death in noncoronary critically ill
patients, identification of patients at high risk of death remains a challenge. In this study, we …

Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis

…, EI Lafferty, DJ Cook, A Fox-Robichaud… - Critical care …, 2011 - journals.lww.com
Objective: To determine the utility of angiopoietin-1 and angiopoietin-2 as potentially novel
biomarkers of morbidity and mortality in patients with severe sepsis. Design: Multicenter …

Cell-free DNA modulates clot structure and impairs fibrinolysis in sepsis

…, DJ Dwivedi, PY Kim, AE Fox-Robichaud… - … , and vascular biology, 2015 - Am Heart Assoc
Objectives— Sepsis is characterized by systemic activation of inflammation and coagulation
in response to infection. In sepsis, activated neutrophils extrude neutrophil extracellular …

[HTML][HTML] Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis

…, A Torres, OT Ranzani, AE Fox-Robichaud… - Intensive care …, 2020 - Springer
The accuracy of the signs and tests that clinicians use to diagnose ventilator-associated
pneumonia (VAP) and initiate antibiotic treatment has not been well characterized. We sought to …

Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial

…, NKJ Adhikari, DC Scales, A Fox-Robichaud… - Intensive care …, 2016 - Springer
Purpose In shock, hypotension may contribute to inadequate oxygen delivery, organ failure
and death. We conducted the Optimal Vasopressor Titration (OVATION) pilot trial to inform …

Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery

…, F Lellouche, A Fox-Robichaud… - Journal of the …, 2018 - journals.lww.com
AKI after cardiac surgery remains strongly associated with mortality and lacks effective
treatment or prevention. Preclinical studies suggest that cell-based interventions may influence …

Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.

A Fox-Robichaud, D Payne, SU Hasan… - The Journal of …, 1998 - Am Soc Clin Investig
Inhaled nitric oxide (NO) is being used more and more in intensive care units as a modality
to improve the outcome of patients with pulmonary complications. Our objective was to …